Operating an unlicensed private in-vitro genetic diagnostic laboratory in Nigeria attracts severe statutory sanctions, including immediate facility sealing, forfeiture of diagnostic equipment, heavy administrative fines, and criminal prosecution carrying prison terms up to two years under the Medical Laboratory Science Council of Nigeria (MLSCN) Act No. 11 of 2003. Operators also face compounding criminal penalties under the National Health Act 2014 and state health facility monitoring statutes for unauthorized handling of human genetic material.
Statutory Regulatory Architecture
Private clinical laboratories analyzing human genetic material, cytogenetics, molecular biology, and in-vitro diagnostic assays are regulated at both federal and state levels. The primary federal regulator is the Medical Laboratory Science Council of Nigeria (MLSCN), established under Act No. 11 of 2003. In addition, the National Health Act 2014 governs biological tissue storage and genetic research ethics, while state agencies like the Lagos State Health Facility Monitoring and Accreditation Agency (HEFAMAA) supervise physical clinic standards.
Specific Penalties Under the MLSCN Act 2003
Section 19 and Section 22 of the MLSCN Act establish strict criminal liability for operating an unregistered medical laboratory or practicing without Council authorization. The statutory penalties include the following enforcement measures:
- Criminal Prosecution and Fines: Section 22 provides that any person who maintains an unregistered laboratory or employs unqualified personnel commits an offense. Convicted individuals face statutory fines or custodial sentences up to two years imprisonment, or both.
- Immediate Facility Sealing: The MLSCN National Quality Assurance and Inspection Directorate exercises statutory police powers to conduct unannounced raids. The Council immediately padlocks, seals, and halts operations at any unaccredited genetic laboratory.
- Confiscation and Forfeiture of Equipment: Diagnostic instruments, thermal cyclers, next-generation sequencing hardware, reagents, and bio-specimen freezers are subject to seizure as evidentiary material during criminal proceedings.
- Professional Deregistration: Any licensed medical laboratory scientist or pathologist found supervising or consulting for an unlicensed genetic diagnostic facility faces disciplinary proceedings before the MLSCN Disciplinary Tribunal, resulting in license revocation.
Severe Penalties Under the National Health Act 2014
Genetic testing involves handling human genomic data, prenatal fetal DNA, and hereditary biological specimens. The National Health Act 2014 introduces stringent prohibitions against unauthorized genetic manipulation and non-compliant sample handling:
- Illegal Tissue and DNA Acquisition: Section 48 and Section 53 of the National Health Act prohibit the commercial dealing, processing, or testing of human genetic tissues without statutory permits. Violations carry custodial sentences of not less than five years imprisonment without option of a fine.
- Cross-Border Export Sanctions: Exporting human genomic samples, DNA profiles, or blood specimens outside Nigeria without clearance from the National Health Research Ethics Committee (NHREC) violates federal biosecurity laws. Operators face severe federal criminal indictments.
- Breach of Genetic Data Privacy: Unlawful disclosure or commercialization of individual genomic test results violates both the National Health Act and the Nigeria Data Protection Act (NDPA) 2023, exposing operators to regulatory fines up to 10,000,000 NGN or two percent of annual gross revenue.
State Level Enforcement Actions and Sanctions
Every State Ministry of Health enforces municipal diagnostic standards. Operating in Lagos State, for instance, without HEFAMAA registration incurs distinct statutory consequences:
- Administrative Sanctions: HEFAMAA levies administrative fines starting from 500,000 NGN up to several million Naira depending on the scope of unauthorized invasive diagnostics performed.
- Public Blacklisting: State authorities publish formal public notices and press releases naming unregistered laboratories to warn prospective patients, destroying corporate reputation.
- Court Injunctions: State attorneys general regularly file motions for perpetual injunctions in State High Courts to restrain delinquent laboratory proprietors from reopening.
Corporate Law Consequences Under CAMA 2020
Under the Companies and Allied Matters Act (CAMA) 2020, registering a corporate entity with the Corporate Affairs Commission (CAC) does not confer medical operating authorization. Operating an illegal diagnostic service constitutes an ultra vires and unlawful corporate undertaking. The Federal High Court may order the compulsory winding up of the company upon application by regulatory bodies or the CAC, and the corporate veil will be pierced to impose direct personal civil and criminal liability on company directors.